You have 9 free searches left this month | for more free features.

Alkylating Agents

Showing 1 - 25 of 5,451

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Fludarabine, busulfan and melphalan
  • Fludarabine and Busulfan
  • Fuzhou, Fujian, China
  • +8 more
Aug 14, 2023

Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

Active, not recruiting
  • Neuroendocrine Tumors
  • Oxaliplatin-based chemotherapy
  • Alkylating-based chemotherapy
  • Amiens, France
  • +18 more
Mar 15, 2022

Gliomas Trial in Miami, Boston, New York (Nivolumab)

Active, not recruiting
  • Gliomas
  • Miami, Florida
  • +3 more
May 5, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Glioma, Glioblastoma Trial in Norway, Sweden (Disulfiram, Copper, Alkylating Agents)

Completed
  • Glioma
  • Glioblastoma
  • Trondheim, Norway
  • +7 more
Mar 16, 2021

Cancer, Toxicity Due to Chemo, Sarcoma Trial in Le Kremlin Bicêtre (Triptorelin (GnRHa) + Chemotherapy)

Unknown status
  • Cancer
  • +5 more
  • Triptorelin (GnRHa) + Chemotherapy
  • Le Kremlin Bicêtre, France
    AP-HP, Bicêtre Hospital
Dec 16, 2019

Drug Induced Neuropathy in Children With ALL

Recruiting
  • Acute Lymphocytic Leukemia
    • Trieste, Friuli Venezia Giulia, Italy
      IRCCS materno infantile Burlo Garofolo
    Mar 31, 2023

    Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation Trial in Worldwide (busulfan, cyclophosphamide and

    Recruiting
    • Acute Myeloid Leukemia (AML) in Remission
    • Stem Cell Transplantation
    • busulfan, cyclophosphamide and melphalan, BuCyMel
    • clofarabine, fludarabine and busulfan, CloFluBu
    • Brussels, Belgium
    • +16 more
    Jul 25, 2022

    High Grade Glioma, Brain Cancer Trial in France (Nivolumab)

    Completed
    • High Grade Glioma
    • Brain Cancer
    • Bordeaux, France
    • +6 more
    Dec 13, 2021

    Breast Cancer Trial in Netherlands (Carboplatin and Paclitaxel, Doxorubicin, cyclophosphamide, Doxorubicin, cyclophosphamide,

    Active, not recruiting
    • Breast Cancer
    • Carboplatin and Paclitaxel
    • +2 more
    • Alkmaar, Netherlands
    • +13 more
    Oct 18, 2021

    Breast Cancer Trial in Amsterdam (carboplatin, thiotepa, and cyclophosphamide, chemo (docetaxel, doxorubicin, cyclofosfamide,

    Recruiting
    • Breast Cancer
    • carboplatin, thiotepa, and cyclophosphamide
    • chemotherapy (docetaxel, doxorubicin, cyclofosfamide, carboplatin, paclitaxel, gemcitabine)
    • Amsterdam, Netherlands
      NKI-AVL
    Mar 21, 2022

    HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)

    Recruiting
    • HER2 Positive Early Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center Shanghai, China, 200032
    Jun 6, 2023

    Rectal Cancer Trial in Milan (External-beam radiation, Capecitabine, Temozolomide)

    Recruiting
    • Rectal Cancer
    • External-beam radiation
    • +2 more
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Jan 25, 2022

    Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)

    Completed
    • Metastatic Colorectal Cancer
    • Milan, MI, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Apr 1, 2022

    Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal

    Not yet recruiting
    • Urothelial Carcinoma
    • +7 more
    • Jelmyto (mitomycin) for pyelocalyceal solution
    • (no location specified)
    May 22, 2023

    Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

    Not yet recruiting
    • Ovarian Cancer
    • Maywood, Illinois
      Loyola University Medical Center
    Aug 1, 2023

    Adult Diffuse Large Cell Lymphoma, Recurrent, Adult Refractory DLBCL Trial in Canada (DPX-Survivac, Pembrolizumab,

    Active, not recruiting
    • Adult Diffuse Large Cell Lymphoma
    • +2 more
    • DPX-Survivac
    • +2 more
    • Calgary, Alberta, Canada
    • +5 more
    Nov 9, 2022

    Disease-free Survival Trial in Shanghai (MBF-RIC)

    Recruiting
    • Disease-free Survival
    • Shanghai, Shanghai, China
    • +1 more
    Jun 28, 2022

    Hodgkin Lymphoma Trial in Italy, United States (Rituximab, Involved field irradiation)

    Terminated
    • Hodgkin Lymphoma
    • Houston, Texas
    • +10 more
    Aug 18, 2021

    Metastatic Colorectal Cancer Trial in Milan (Bevacizumab, Irinotecan, Leucovorin)

    Recruiting
    • Metastatic Colorectal Cancer
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Apr 1, 2022

    Short Term Genetic Effects of Chemotherapy on Male Germ Cells

    Recruiting
    • Cancer
    • Semen collection and analysis
    • Pittsburgh, Pennsylvania
      Magee-Womens Hospital
    May 19, 2022

    Squamous Cell Carcinoma of the Head and Neck Trial in Tampa (Cisplatin, Stereotactic Body Radiation Therapy (SBRT))

    Active, not recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • Cisplatin
    • Stereotactic Body Radiation Therapy (SBRT)
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Mar 22, 2022

    Glioma, Gliomas, High Grade Glioma Trial run by the National Cancer Institute (NCI) (3T MRI scanner)

    Recruiting
    • Glioma
    • +4 more
    • 3T MRI scanner
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Idiopathic Membranous Nephropathy

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • Obinutuzumab Injection
    • (no location specified)
    May 8, 2023

    Amyloidosis Trial in Athens (Lenalidomide, Dexamethasone and Cyclophosphamide)

    Completed
    • Amyloidosis
    • Lenalidomide, Dexamethasone and Cyclophosphamide
    • Athens, Attica, Greece
      Alexandra Hospital , Department of Clinical Therapeutics
    Apr 27, 2021